DongKook Pharmaceutical Co., Ltd.

KOSDAQ 086450.KQ

DongKook Pharmaceutical Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2023: 11.11%

DongKook Pharmaceutical Co., Ltd. Return on Capital Employed (ROCE) is 11.11% for the year ending December 31, 2023, a -11.87% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.

DongKook Pharmaceutical Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2022 was 12.61%, a 1.19% change year over year.
DongKook Pharmaceutical Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2021 was 12.46%, a -21.97% change year over year.
DongKook Pharmaceutical Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2020 was 15.97%, a 0.92% change year over year.
DongKook Pharmaceutical Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2019 was 15.82%, a 11.34% change year over year.

Key data

Date	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio	Return on Common Equity

KOSDAQ: 086450.KQ

DongKook Pharmaceutical Co., Ltd.

CEO	Mr. Heung-Ju Oh
IPO Date	May 29, 2007
Location	South Korea
Headquarters	7, Teheran-ro 108-gil
Employees	1,092
Sector	Health Care
Industries Pharmaceuticals

Description

DongKook Pharmaceutical Co., Ltd. provides pharmaceutical products in South Korea and internationally. It produces active pharmaceutical ingredients, including propofol, streptokinase, and teicoplanin; disposable syringes; and pills, capsules, and ointments, as well as small volume parentral, large volume parentral, and lyophilized injectable drug injections. The company also offers Teicon, Durakinase, and Lorelin Depot injections; produces various natural product materials, such as black cohosh extract and magnolia extract comprises ETIZM and TECA; and natural herb medicines. In addition, it provides general and prescription-based drugs; medical devices; ETC and cosmetic products; and quasi drugs that include lipossol hydrocare bandage. DongKook Pharmaceutical Co., Ltd. also exports its products to approximately 40 countries, including Japan, Europe, Central and South America, and India. The company was formerly known as UEC & Co., Ltd. and changed its name to DongKook Pharmaceutical Co., Ltd. in March 1982. DongKook Pharmaceutical Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea.

Key trends

Past 5 years